22.7 C
New York
Wednesday, September 22, 2021
spot_img

Wall Street’s Key Stock Analysts Research Reports, All Buys

#stocks#bullish#buys#analysts#research#WallStreet

$ACVA $BILI $CADL $MXCT $RLYB

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.

These are all Buys if you can manage the risk.

Below are our Buys for Tuesday, 24 August, as follows:

ACV Auctions Inc. (NASDAQ:ACVA): Citigroup upgraded the stock to Buy from Neutral but dropped the target price to 23 from 29. The consensus target is 36.

Bilbili Inc. (NASDAQ:BILI): Goldman reiterated a Buy rating and cut its price target to 105 from $122. Shares traded in a 52-wk range of 40.40 – 157.66.

Candel Therapeutics Inc. (NASDAQ:CADL): UBS initiated coverage with a Buy rating and a 9 price target. Credit Suisse started it with an Outperform rating and a 15 price target, and Jefferies started it with a Buy rating and a 22 price target.

MaxCyte Inc. (NASDAQ:MXCT): Stifel initiated coverage with a Buy rating and an 18 price target. BTIG started it with a Buy rating and a 22 price target. The stock trades in a 52-wk range of 13.77 – 17.44.

Rallybio Corp. (NASDAQ:RLYB): Jefferies started coverage with a Buy rating and a 20 price target. Since the IPO, the shares have traded between 11.86 – 25.78

Have a prosperous day, Keep the Faith!

Paul Ebeling
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Related Articles

Stay Connected

15,334FansLike
43,300FollowersFollow
2,855SubscribersSubscribe
- Advertisement -spot_img

Latest Articles